Denali Capital Acquisition Corp. Warrant
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch DNQWF and buy or sell other stocks, ETFs, and their options commission-free!About DNQWF
Semnur Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company focused on developing and commercializing innovative non-opioid pain management products for the treatment of acute and chronic pain. Its lead product candidate, SP-102, is a non-opioid novel injectable corticosteroid gel formulation for patients with moderate to severe lumbosacral radicular pain.
CEOJaisim Shah, MBA
CEOJaisim Shah, MBA
Employees—
Employees—
HeadquartersPalo Alto, California
HeadquartersPalo Alto, California
Founded
Founded
Employees—
Employees—
DNQWF Key Statistics
Market cap—
Market cap—
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume5.90K
Average volume5.90K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.00
52 Week high$1.00
52 Week low$0.0056
52 Week low$0.0056
Stock Snapshot
As of today, Denali Capital Acquisition Corp. Warrant(DNQWF) shares are valued at $0.14.
On 2025-12-13, Denali Capital Acquisition Corp. Warrant(DNQWF) stock opened at —, reached a high of —, and a low of —.
The Denali Capital Acquisition Corp. Warrant(DNQWF)'s current trading volume is 0, compared to an average daily volume of 5.9K.
In the last year, Denali Capital Acquisition Corp. Warrant(DNQWF) shares hit a 52-week high of $1.00 and a 52-week low of $0.01.
In the last year, Denali Capital Acquisition Corp. Warrant(DNQWF) shares hit a 52-week high of $1.00 and a 52-week low of $0.01.